Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update reporting the safety and efficacy evaluation of ASP015K in adults with moderate to severe rheumatoid arthritis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ASP015K

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED